Mortality rates and hemorrhagic complications in Asian-Pacific islanders during treatment of acute, myocardial infarction

被引：5

作者：

Kuo, PI

Severino, R

Pashkow, FJ

机构：

[1] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA

[2] Queens Med Ctr, Honolulu, HI USA

[3] Sanofi Synthelabo Inc, New York, NY USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 05期

关键词：

D O I：

10.1016/j.amjcard.2004.05.032

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The investigators hypothesized that aggressive antiplatelet and anticoagulation therapies used in the management of acute myocardial infarction (AMI) may unmask subclinical defects in platelet function and coagulation. Analysis of hemorrhagic complications in 1,983 patients admitted for AMI suggests genetic and pathologic causes. (C) 2004 by Excerpta Medica, Inc.

引用

收藏

页码：644 / 646

页数：3

相关论文

共 9 条

[1] Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction [J].

Berkowitz, SD ;

Granger, CB ;

Peiper, KS ;

Lee, KL ;

Gore, JM ;

Simoons, M ;

Armstrong, PW ;

Topol, EJ ;

Califf, RM .

CIRCULATION, 1997, 95 (11) :2508-2516

[2] Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction [J].

Berkowitz, SD ;

Stinnett, S ;

Cohen, M ;

Fromell, GJ ;

Bigonzi, F .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (11) :1230-1234

[3] ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction [J].

Braunwald, E ;

Antman, EM ;

Beasley, JW ;

Califf, RM ;

Cheitlin, MD ;

Hochman, JS ;

Jones, RH ;

Kereiakes, D ;

Kupersmith, J ;

Levin, TN ;

Pepine, CJ ;

Schaeffer, JW ;

Smith, EE ;

Steward, DE ;

Theroux, P ;

Gibbons, RJ ;

Alpert, JS ;

Eagle, KA ;

Faxon, DP ;

Fuster, V ;

Gardner, TJ ;

Gregoratos, G ;

Russell, RO ;

Smith, SC .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :970-1056

[4] Hemorrhagic complications of intravenous heparin use [J].

Juergens, CP ;

Semsarian, C ;

Keech, AC ;

Beller, EM ;

Harris, PJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (02) :150-154

[5] HEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC THERAPY [J].

LAUER, JE ;

HEGER, JJ ;

MIRRO, MJ .

CHEST, 1995, 108 (06) :1520-1523

[6]

Madan M, 1999, Curr Opin Hematol, V6, P334, DOI 10.1097/00062752-199909000-00011

[7] Uremic bleeding: Closing the circle after 30 years of controversies? [J].

Noris, M ;

Remuzzi, G .

BLOOD, 1999, 94 (08) :2569-2574

[8] RACE AND PROGNOSIS AFTER MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) PHASE-II TRIAL [J].

TAYLOR, HA ;

CHAITMAN, BR ;

ROGERS, WJ ;

KERN, MJ ;

TERRIN, ML ;

AGUIRRE, FV ;

SOPKO, G ;

MCMAHON, R ;

ROSS, RN ;

BOVILL, EC .

CIRCULATION, 1993, 88 (04) :1484-1494

[9] Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery [J].

Winkelmayer, WC ;

Levin, R ;

Avorn, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :84-89